6-K

REPORT OF FOREIGN PRIVATE ISSUER

Company: Sofgen Pharma S.A.
Filed: September 5, 2023
Period of Report: September 5, 2023
Accession Number: 0001213900-23-073596

View Document ↗ View on SEC.gov ↗